South Korea Multi Cancer Early Detection Market Size & Outlook

The multi cancer early detection market in South Korea is expected to reach a projected revenue of US$ 60.5 million by 2030. A compound annual growth rate of 12.3% is expected of South Korea multi cancer early detection market from 2023 to 2030.
Revenue, 2022 (US$M)
$24.0
Forecast, 2030 (US$M)
$60.5
CAGR, 2023 - 2030
12.3%
Report Coverage
South Korea

South Korea multi cancer early detection market, 2018-2030 (US$M)

South

South Korea multi cancer early detection market highlights

  • The South Korea multi cancer early detection market generated a revenue of USD 24.0 million in 2022 and is expected to reach USD 60.5 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 12.3% from 2023 to 2030.
  • In terms of segment, gene panel, ldt & others was the largest revenue generating type in 2022.
  • Gene Panel, LDT & Others is the most lucrative type segment registering the fastest growth during the forecast period.


Multi cancer early detection market data book summary

Market revenue in 2022USD 24.0 million
Market revenue in 2030USD 60.5 million
Growth rate12.3% (CAGR from 2022 to 2030)
Largest segmentGene panel, ldt & others
Fastest growing segmentGene Panel, LDT & Others
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGene Panel, LDT & Others
Key market players worldwideIllumina Inc, Exact Sciences Corp, Foundation Medicine, Guardant Health Inc, Burning Rock Biotech Ltd ADR, Freenome, AnchorDx, GeneCast, Elypta


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.8% of the global multi cancer early detection market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China multi cancer early detection market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 97.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Multi Cancer Early Detection Market Companies

Name Profile # Employees HQ Website

South Korea multi cancer early detection market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multi cancer early detection market will help companies and investors design strategic landscapes.


Gene panel, ldt & others was the largest segment with a revenue share of 100% in 2022. Horizon Databook has segmented the South Korea multi cancer early detection market based on gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.


Increasing R&D investments by key pharmaceutical companies in South Korea are expected to create a lucrative environment for market growth. For instance, in October 2022, AstraZeneca announced that it will spend USD 630.0 million on R&D in South Korea over the next 5 years to improve access to healthcare.

Reasons to subscribe to South Korea multi cancer early detection market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea multi cancer early detection market databook

  • Our clientele includes a mix of multi cancer early detection market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea multi cancer early detection market , including forecasts for subscribers. This country databook contains high-level insights into South Korea multi cancer early detection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea multi cancer early detection market size, by type, 2018-2030 (US$M)

South Korea Multi Cancer Early Detection Market Outlook Share, 2022 & 2030 (US$M)

South Korea multi cancer early detection market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more